// App-Quantinova.ai

POS0520 (2022) : ASSOCIATION BETWEEN BASELINE STATIN TREATMENT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF ORAL SURVEILLANCE

Researchers

Presenter

  • J. T. Giles

Principal Investigators

  • C. Charles-Schoeman

  • M. H. Buch

  • M. Dougados

  • Z. Szekanecz

  • S. R. Ytterberg

  • G. G. Koch

  • J. Wu

  • C. Wang

  • K. Kwok

  • S. Menon

  • Y. Chen

  • T. Y. Cesur

  • J. L. Rivas

  • A. Yndestad

  • A. Diehl

  • D. L. Bhatt

Medical Centers

  • Columbia University Vagelos College of Physicians and Surgeons, Division of Rheumatology, New York, NY, United States of America

  • University of California Los Angeles, Division of Rheumatology, Department of Medicine, Los Angeles, CA, United States of America

  • University of Manchester and NIHR Manchester Biomedical Research Centre, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Manchester, United Kingdom

  • Hôpital Cochin. Assistance Publique - Hôpitaux de Paris, Department of Rheumatology, Paris, France

  • PRES Sorbonne Paris-Cité, INSERM (U1153): Clinical Epidemiology and Biostatistics, Paris, France

  • University of Debrecen, Division of Rheumatology, Faculty of Medicine, Debrecen, Hungary

  • Mayo Clinic, Rheumatology, Rochester, MN, United States of America

  • University of North Carolina at Chapel Hill. Dept Genetics, Chapel Hill, United States of America

  • Pfizer Inc, Inflammation and Immunology, Peapack, NJ, United States of America

  • Pfizer Inc, Inflammation and Immunology, Peapack, NJ, United States of America

  • Pfizer Turkey, Inflammation and Immunology, Istanbul, Turkey

  • Pfizer Inc, Inflammation and Immunology, Paris, France

  • Pfizer Inc, Inflammation and Immunology, Oslo, Norway

  • Pfizer Inc, Inflammation and Immunology, Peapack, NJ, United States of America

  • Brigham and Women’s Hospital and Harvard Medical School, Department of Cardiovascular Medicine, Boston, MA, United States of America

Locations

  • United States

  • United Kingdom

  • France

  • Hungary

  • Turkey

  • Spain

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Rheumatoid arthritis

  • Diabetes

  • Coronary Artery Disease

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Tasocitinib

  • Adalimumab

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Randomized

  • Cohort

Phase

  • N/A

Study Id's

  • NCT02092467

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved